Abstract
Adaptor protein complex 4 (AP-4) plays a key role in vesicle formation, trafficking, and sorting processes that are critical for brain development and function. AP-4 consists of four subunits encoded by the AP4E1, AP4B1, AP4M1, and AP4S1 genes. A number of studies have pointed to the involvement of AP-4–mediated vesicular trafficking pathways in the etiology of cerebral palsy (CP), the most notable of which are the causative mutations that have recently been identified in each of the AP-4 genes in different CP families. We postulated, therefore, that variations in AP-4 genes might influence an indivual’s susceptibility to CP. In the present study, 16 SNPs were genotyped among 517 CP patients and 502 healthy controls from the Han Chinese population. We systematically analyzed the association of the AP4E1, AP4B1, AP4M1, and AP4S1 genes with CP on the basis of clinical characteristics. No significant associations were found between these variants and the overall risk of CP. Subgroup analysis showed that rs1217401 of AP4B1 was significantly associated with CP as a sequela of hypoxic-ischemic encephalopathy (HIE) (CP + HIE) (allele: p = 0.042151; genotype: p = 4.46 × 10−6). Our results indicate that the 16 variants studied in the genes of the four subunits of AP-4 have no detectable effects on the overall susceptibility to CP, but AP4B1 appears to be a susceptibility gene for CP + HIE in the Han Chinese population.
Similar content being viewed by others
References
Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D (2005) Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 47(8):571–576
Novak I, Hines M, Goldsmith S, Barclay R (2012) Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics 130(5):e1285–e1312
Kuban KC, Leviton A (1994) Cerebral palsy. N Engl J Med 330(3):188–195
Liu J, Li Z, Lin Q, Zhao P, Zhao F, Hong S, Li S (2000) Cerebral palsy and multiple births in China. Int J Epidemiol 29(2):292–299
Schaefer GB (2008) Genetics considerations in cerebral palsy. Semin Pediatr Neurol 15(1):21–26
Nelson KB (2008) Causative factors in cerebral palsy. Clin Obstet Gynecol 51(4):749–762
Moreno-De-Luca A, Ledbetter DH, Martin CL (2012) Genetic insights into the causes and classification of the cerebral palsies. Lancet Neurol 11(3):283–292
Garne E, Dolk H, Krageloh-Mann I, Ravn SH, Cans C, Grp SC (2008) Cerebral palsy and congenital malformations. Eur J Paediatr Neurol 12(2):82–88
Blair E, Al Asedy F, Badawi N, Bower C (2007) Is cerebral palsy associated with birth defects other than cerebral defects? Dev Med Child Neurol 49(4):252–258
Hemminki K, Li X, Sundquist K, Sundquist J (2007) High familial risks for cerebral palsy implicate partial heritable aetiology. Paediatr Perinat Epidemiol 21(3):235–241
Gustavson KH, Hagberg B, Sanner G (1969) Identical syndromes of cerebral palsy in the same family. Acta Paediatr Scand 58(4):330–340
Costeff H (2004) Estimated frequency of genetic and nongenetic causes of congenital idiopathic cerebral palsy in west Sweden. Ann Hum Genet 68:515–520
McHale DP, Jackson AP, Campbell Levene MI, Corry P, Woods CG, Lench NJ, Mueller RF, Markham AF (2000) A gene for ataxic cerebral palsy maps to chromosome 9p12-q12. Eur J Hum Genet 8(4):267–272
Abou Jamra R, Philippe O, Raas-Rothschild A, Eck SH, Graf E, Buchert R, Borck G, Ekici A, Brockschmidt FF, Nothen MM, Munnich A, Strom TM, Reis A, Colleaux L (2011) Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 88(6):788–795
Yap CC, Murate M, Kishigami S, Muto Y, Kishida H, Hashikawa T, Yano R (2003) Adaptor protein complex-4 (AP-4) is expressed in the central nervous system neurons and interacts with glutamate receptor delta2. Mol Cell Neurosci 24(2):283–295
Matsuda S, Miura E, Matsuda K, Kakegawa W, Kohda K, Watanabe M, Yuzaki M (2008) Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. Neuron 57(5):730–745
Kashiwabuchi N, Ikeda K, Araki K, Hirano T, Shibuki K, Takayama C, Inoue Y, Kutsuwada T, Yagi T, Kang Y et al (1995) Impairment of motor coordination, Purkinje cell synapse formation, and cerebellar long-term depression in GluR delta 2 mutant mice. Cell 81(2):245–252
Kurihara H, Hashimoto K, Kano M, Takayama C, Sakimura K, Mishina M, Inoue Y, Watanabe M (1997) Impaired parallel fiber --> Purkinje cell synapse stabilization during cerebellar development of mutant mice lacking the glutamate receptor delta2 subunit. J Neurosci 17(24):9613–9623
Horton AC, Ehlers MD (2003) Neuronal polarity and trafficking. Neuron 40(2):277–295
Metzler M, Li B, Gan L, Georgiou J, Gutekunst CA, Wang Y, Torre E, Devon RS, Oh R, Legendre-Guillemin V, Rich M, Alvarez C, Gertsenstein M, McPherson PS, Nagy A, Wang YT, Roder JC, Raymond LA, Hayden MR (2003) Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking. EMBO J 22(13):3254–3266
Moreno-De-Luca A, Helmers SL, Mao H, Burns TG, Melton AM, Schmidt KR, Fernhoff PM, Ledbetter DH, Martin CL (2011) Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 48(2):141–144
Verkerk AJ, Schot R, Dumee B, Schellekens K, Swagemakers S, Bertoli-Avella AM, Lequin MH, Dudink J, Govaert P, van Zwol AL, Hirst J, Wessels MW, Catsman-Berrevoets C, Verheijen FW, de Graaff E, de Coo IF, Kros JM, Willemsen R, Willems PJ, van der Spek PJ, Mancini GM (2009) Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 85(1):40–52
Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, Hosseini M, Behjati F, Haas S, Jamali P, Zecha A, Mohseni M, Puttmann L, Vahid LN, Jensen C, Moheb LA, Bienek M, Larti F, Mueller I, Weissmann R, Darvish H, Wrogemann K, Hadavi V, Lipkowitz B, Esmaeeli-Nieh S, Wieczorek D, Kariminejad R, Firouzabadi SG, Cohen M, Fattahi Z, Rost I, Mojahedi F, Hertzberg C, Dehghan A, Rajab A, Banavandi MJ, Hoffer J, Falah M, Musante L, Kalscheuer V, Ullmann R, Kuss AW, Tzschach A, Kahrizi K, Ropers HH (2011) Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478(7367):57–63
Bauer P, Leshinsky-Silver E, Blumkin L, Schlipf N, Schroder C, Schicks J, Lev D, Riess O, Lerman-Sagie T, Schols L (2012) Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47). Neurogenetics 13(1):73–76
Cans C (2000) Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol 42:816–824
Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L, Ji L, Guo X, Xiong H, Simbruner G, Blomgren K, Wang X (2009) Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124(2):e218–e226
Ruis KA, Lehmann CU, Northington FJ, Lin DD, Graham EM (2009) Neonatal brain imaging and the identification of metabolic acidemia and hypoxic-ischemic encephalopathy. J Matern Fetal Neonatal Med 22(10):823–828
Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191
Himmelmann K (2013) Epidemiology of cerebral palsy. Handbook of clinical neurology 111:163–167
O’Callaghan ME, MacLennan AH, Haan EA, Dekker G (2009) The genomic basis of cerebral palsy: a HuGE systematic literature review. Hum Genet 126:149–172
Nielsen LF, Schendel D, Grove J, Hvidtjorn D, Jacobsson B, Josiassen T, Vestergaard M, Uldall P, Thorsen P (2008) Asphyxia-related risk factors and their timing in spastic cerebral palsy. BJOG 115(12):1518–1528
Bundey S, Griffiths MI (1977) Recurrence Risks in Families of Children with Symmetrical Spasticity. Dev Med Child Neurol 19(2):179–191
Hagberg H, Thornberg E, Blennow M, Kjellmer I, Lagercrantz H, Thiringer K, Hamberger A, Sandberg M (1993) Excitatory amino-acids in the cerebrospinal-fluid of asphyxiated infants—relationship to hypoxic-ischemic encephalopathy. Acta Paediatr 82(11):925–929
Pu YL, Li QF, Zeng CM, Gao J, Qi J, Luo DX, Mahankali S, Fox PT, Gao JH (2000) Increased detectability of alpha brain glutamate/glutamine in neonatal hypoxic-ischemic encephalopathy. Am J Neuroradiol 21(1):203–212
Johnston MV (2005) Excitotoxicity in perinatal brain injury. Brain Pathol 15(3):234–240
Wood TL, Loladze V, Altieri S, Gangoli N, Levison SW, Brywe KG, Mallard C, Hagberg H (2007) Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev Neurosci 29(4–5):302–310
Nakanishi N, Tu S, Shin Y, Cui J, Kurokawa T, Zhang D, Chen HS, Tong G, Lipton SA (2009) Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci 29(16):5260–5265
Fuchs SA, Peeters-Scholte CMPCD, de Barse MMJ, Roeleveld MW, Klomp LWJ, Berger R, de Koning TJ (2012) Increased concentrations of both NMDA receptor co-agonists d-serine and glycine in global ischemia: a potential novel treatment target for perinatal asphyxia. Amino Acids 43(1):355–363
Johnston MV (2005) Excitotoxicity in perinatal brain injury. Brain Pathol 15(3):234–240
Northington FJ, Chavez-Valdez R, Martin LJ (2011) Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 69(5):743–758
Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22(10):1302–1306
Neale BM, Sham PC (2004) The future of association studies: gene-based analysis and replication. Am J Hum Genet 75(3):353–362
Acknowledgments
We are grateful to all the participants in this study. This work was supported by a Grant from National Natural Science Foundation of China (No: 90919049, 30971582, 31271152, 81261120400, 61240031), the 973 Program (2011CB504501), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the Health Department of Henan Province (201201002), the Swedish Research Council (VR) and Swedish governmental grants to scientists working in health care (ALF).
Author information
Authors and Affiliations
Corresponding authors
Additional information
H. Wang and Y. Xu contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, H., Xu, Y., Chen, M. et al. Genetic association study of adaptor protein complex 4 with cerebral palsy in a Han Chinese population. Mol Biol Rep 40, 6459–6467 (2013). https://doi.org/10.1007/s11033-013-2761-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-013-2761-6